Oral vitamin D3 supplementation for chronic plaque psoriasis: A randomized, double-blind, placebo-controlled trial.
J Dermatolog Treat. 2018 Feb 26:1-34. doi: 10.1080/09546634.2018.1444728
Ingram MA1, Jones MB2, Stonehouse W3, Jarrett P4,5, Scragg R6, Mugridge O1, von Hurst PR1.
1 School of Sport, Exercise and Nutrition, Massey Univ., Albany Campus , Private Bag 102904 , North Shore City , Auckland 0745 , New Zealand.
2 Institute of Natural and Mathematical Sciences, Massey Univ., Albany Campus , Private Bag 102904 , North Shore City , Auckland 0745 , New Zealand.
3 Commonwealth Scientific and Industrial Research Organisation, Food and Nutrition Flagship , Adelaide , South Australia 5000 , Australia.
4 Department of Dermatology , Middlemore Hospital , Otahuhu , Auckland 1640 , New Zealand.
5 Department of Medicine , The University of Auckland , Auckland 1072 , New Zealand.
6 School of Population Health, The University of Auckland , Auckland 1142 , New Zealand.
- Psoriasis – less frequent and shorter duration with higher vitamin D (45 ng is nice) – Dec 2016
- Psoriasis severity associated with low vitamin D (10 studies) – meta-analysis Jan 2018
- Dermatologists are reminded of the importance of vitamin D in 8 diseases – Oct 2017
- Psoriasis proven to be treated by Vitamin D in many RCT, but dermatologists fear losing business – March 2015
Need a lot more Vitamin D
Topical Vitamin D works well
UV also works well
Purpose The management of psoriasis remains a challenge for dermatologist and patient. This study aimed to determine whether vitamin D3 supplementation improves psoriasis compared to placebo.
Materials and methods In a randomized, doubled-blind, placebo-controlled trial, 101 participants ≥18 years with psoriasis were grouped by severity and allocated to 100,000 International Units (IU) vitamin D3/month for 12 months (200,000 IU at baseline; n = 67) or an identical placebo (n = 34). Psoriasis Area and Severity Index (PASI) and serum 25(OH)D concentrations were assessed at 3-monthly intervals. The primary outcome was the difference in PASI between groups over time. The relationship between 25(OH)D and PASI across the sample was also considered in a post hoc analysis.
Results PASI did not differ between groups at any time (group F(1,104)=0.48, P = 0.49; group*time F(4,384)=0.26, P = 0.90). However, 25(OH)D increased in both groups, rendering these findings inconclusive. A significant inverse relationship existed between PASI and 25(OH)D, with elevation of 25(OH)D by up to 125 nmol/L associated with mild decreases in PASI (estimated range of decrease 0 - 2.6; P = 0.002).
Conclusions A direct benefit of vitamin D3 supplementation for psoriasis could not be determined. However, these findings suggest a relationship between 25(OH)D and psoriasis severity, at least in some subgroups.
Title change made March 2022 caused the visitor count to reset.There have actually been
99 visitors, last modified 11 Mar, 2022, |